Results 131 to 140 of about 6,619,981 (269)

Detection of single amino acid mutation in human breast cancer by disordered plasmonic self-similar chain [PDF]

, 2015
Maria Laura Coluccio, Francesco Gentile, Gobind Das, Annalisa Nicastri, Antonio Perri, Patrizio Candeloro, Gerardo Perozziello, Remo Proietti Zaccaria, Juan Sebastian Totero Gongora, Salma Alrasheed, Andrea Fratalocchi, Tania Limongi, Giovanni Cuda, Enzo Di Fabrizio   +13 more
openalex   +1 more source

Clinical indicators for the incidence of postoperative ileus after elective surgery for colorectal cancer [PDF]

, 2021
Yosuke Namba, Yuzo Hirata, Shoichiro Mukai, Sho Okimoto, Seiji Fujisaki, Mamoru Takahashi, Toshikatsu Fukuda, Hideki Ohdan   +7 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum

, 2013
Xiaoli Zhang, Luan Xu, Jianmin Shen, Bei Cao, Ting Cheng, Tong Zhao, Xiaoyan Liu, Haixia Zhang   +7 more
openalex   +2 more sources

Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial [PDF]

, 2017
L. Ek, Emelie Gezelius, Bengt Bergman, Pär‐Ola Bendahl, H. Anderson, J. Sundberg, M. Wallberg, Sture Falkmer, Sunil Verma, Mattias Belting   +9 more
openalex   +1 more source

Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B‐cell lymphoma

, 2021
Se‐Il Go, Mi Jung Park, Sungwoo Park, Myoung Hee Kang, Hoon‐Gu Kim, Jung Hun Kang, Jung Hoon Kim, Gyeong‐Won Lee   +7 more
openalex   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

Sex Matters: Hormonal and Chromosomal Determinants of Autoimmunity and Anti-Cancer Immunity Across the Lifespan. [PDF]

Immunol Rev
Bustillos CG, Peluso EM, Cha SL, Lechner MG, Su MA.   +4 more
europepmc   +1 more source

Community-based exercise program effectiveness and safety for cancer survivors

, 2012
Emily Jo Rajotte, Jean C. Yi, K. Scott Baker, Lindsey Gregerson, Andréa Leiserowitz, Karen L. Syrjala   +5 more
openalex   +2 more sources